Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Accumulated Expenses (2016 - 2019)

Traws Pharma (TRAW) has disclosed Other Accumulated Expenses for 7 consecutive years, with $14000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $14000.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $14000.0, a N/A change, with the full-year FY2018 number at $13000.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $14000.0 for Q1 2019 at Traws Pharma, up from $13000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $243000.0 in Q3 2016 to a low of $6000.0 in Q4 2015.
  • A 4-year average of $94800.0 and a median of $14000.0 in 2019 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: crashed 73.91% in 2015, then surged 3200.0% in 2016.
  • Traws Pharma's Other Accumulated Expenses stood at $6000.0 in 2015, then soared by 3200.0% to $198000.0 in 2016, then plummeted by 93.43% to $13000.0 in 2018, then rose by 7.69% to $14000.0 in 2019.
  • Per Business Quant, the three most recent readings for TRAW's Other Accumulated Expenses are $14000.0 (Q1 2019), $13000.0 (Q4 2018), and $198000.0 (Q4 2016).